Common use of Cross-Referencing Clause in Contracts

Cross-Referencing. To the extent required by GSK, or an Affiliate or Sublicensee of GSK to the Products, CureVac hereby authorizes GSK, its Affiliates and Sublicensees to cross reference to the sections of the regulatory dossiers of the clinical trials related to any other mRNA-Based product in the Field in development by CureVac or its Affiliates to the extent under the Control of CureVac. GSK shall notify CureVac in writing prior to any such cross-referencing. GSK will consider in good faith any request of CureVac or any of its Affiliates to authorize cross-referencing to the sections of the regulatory dossiers of the clinical trials related to the Products.

Appears in 2 contracts

Sources: Fourth Amendment and Restatement Agreement (CureVac N.V.), 2020 Cla Amendment and Restatement Agreement (CureVac N.V.)